Holiday Notice: Due to the observation of Memorial Day 2017, orders placed after 2:00pm EST on Friday, May 26 will not be shipped until Tuesday, May 30.
Monday, January 16, 2017
Aidance Scientific subsidiary CBD CLINIC producing new over-the-counter pain ointment.
BY NANCY KIRSCH CONTRIBUTING WRITER
PROVIDENCE – CBD CLINIC, a subsidiary of Aidance Scientific, a Woonsocket company that develops and manufactures an extensive line of over-the-counter dermatology products, has launched a new array of topical pain treatments. CBD CLINIC’s new line of products combine U.S. Food and Drug Administration-approved analgesic ingredients – such as camphor, menthol and lidocaine – with a hemp extract called cannabidiol, or CBD. The products are designed to treat a wide array of muscular skeletal pain, such as that occurring due to arthritis, rheumatoid arthritis, fibromyalgia, multiple sclerosis, general aging, sports injuries, etc.
As the products are nearly free of THC, the substance in marijuana that gets people high, they can be produced in Rhode Island and sold nationally, the company reported. The CBD oil contains less than 0.3 percent of THC, which is below the threshold established by the U.S. Drug Enforcement Agency; once the oil is put into formulation, it’s diluted to nearly undetectable amounts, said David Goldsmith, co-founder of Aidance Scientific. The company describes the product series thusly: “Doesn’t get you high. Just better.” Read More
Although the retail series of four products is not available yet at sporting goods stores, fitness centers or drugstores, consumers can purchase them on a discounted basis during the company’s crowdfunding initiative, scheduled through January and, perhaps, February. Beyond the crowdfunding, CBD CLINIC has not yet determined whether it will sell the retail series online or exclusively through retail operations, Goldsmith said.
Currently, five products in the professional series – more potent than the retail series – are being sold to health care professionals, including chiropractors, osteopaths and massage therapists, who then sell them to their customers, although the company has not yet tapped the Rhode Island market. “We have not yet had the time to really develop the local market … we’d love to be able to make this [commercial product line] available to health care providers in Rhode Island and nearby Massachusetts and Connecticut,” said Goldsmith. Such health care professionals can purchase these products through the CBD CLINIC website or distributors around the country.
Goldsmith, who is also board president and co-founder of Med-Mates, a life sciences technology networking group, told Providence Business News that CBD CLINIC’s products – some are water-based creams and others are oil-based ointments – are different than other companies’ offerings.
“They are the first to incorporate FDA-approved analgesic ingredients [with CBD that are being] produced in an FDA-compliant, FDA-audited manufacturing facility,” he said, noting that Aidance Scientific and CBD CLINIC have the exclusive right to formulate products with the patented Charlotte’s Web CBD. The products’ entire formulation, designed to facilitate skin absorption, offers an alternative, said Goldsmith, that doctors describe as “nothing they’ve ever used before.” The CBD CLINIC products have no competition now in this specific market, as no other company has an FDA-registered product line that combines FDA-approved active ingredients and any cannabidiol, said Goldsmith.
Price points for a professional series range from $25 to $90 for a 1.5-ounce jar, which should last the typical user approximately four to six weeks, and Goldsmith said that many practitioners report that their patients opt for the most potent of these products, at $90. Although some patients are initially hesitant to purchase the products, given the price point, Goldsmith said many have found the products, which have a money-back guarantee, to be more effective than anything else they’ve tried before. Retail prices will range from $49 to $69 for a 1-ounce tube, which should last the typical user one month, he said.
Declining to reveal sales information on CBD CLINIC products, which have been sold since July 2016, Goldsmith said the demand has been much stronger than they expected. Of Aidance Scientific, whose employee base has grown from about 20 individuals one year ago to approximately 33 now, Goldsmith said, “We really believe that the CBD CLINIC line and everything we’re doing has the potential to grow very rapidly … and it’s all being produced here in Woonsocket.” With three full-time employees, CBD CLINIC is supported by Aidance Scientific employees in supply-chain management, marketing, formulation development and other areas, said Goldsmith.
January 5, 2017 BostonBakedPete
Cannabis CBD Cream Goes Live On IndieGoGo
All Federally Legal And You Can Get Some Today
Interesting new crowdfunder just hit and it has to to with CBD and marijuana. A new cannabis-infused, topical pain relief product is now available for pre-purchase. CBD CLINIC™ is currently funding wider distribution of their CBD-infused topical pain relievers via a crowdfunding campaign on Indiegogo. (Click here to see it)
Medical cannabis use has been associated with pain relief for years. However, the Rhode Island-based startup has a new approach to cannabis in pain relief: CBD-infused ointments and creams that are safe, legal everywhere, and won’t show up in a drug test.
The company was founded by Ari Taube, David Goldsmith and Perry Antelman in 2015 with the mission of breaking down the stigmas associated with typical cannabis-based treatment for pain. For them, it was important from the start to create a product that is nearly devoid of THC so that it could be legally distributed and sold anywhere in the United States without a prescription.
Read More Charlotte’s Web became the clear choice for an exclusive supplier of CBD hemp oil. They were chosen for their dedication to the quality and purity of their crop -a result of strict control and guidelines that ensure their soil is clean and free of heavy metals. CBD CLINIC uses Charlotte’s Web CBD hemp oil along with FDA-approved analgesics to stop tough pain and provide lasting relief.
Charlotte’s Web’s unique approach to growing cannabidiol-rich marijuana strains low in THC has become a crucial step in changing public opinion about what marijuana-adjacent pharmaceuticals can be. Because of this approach, CBD CLINIC sources CBD hemp oil exclusively from the Colorado-based company. With no psychoactive effects, CBD CLINIC products are safe for anyone to use, without having to worry about a positive drug test.
With these ideals in mind, CBD CLINIC’s tagline became, “Doesn’t get you high. Just better.”
Pursuing a different regulatory strategy than most medical marijuana products (which contain THC), CBD CLINIC products were developed to easily manage many of the hurdles cannabis-related products face with state-regulation of THC. This allowed CBD CLINIC to quickly get its products into the hands of those suffering from pain. CBD-based products allow users whose states have not yet legalized medical marijuana legal access to an effective pain relief option.
The company was spun off from its parent company, Aidance Scientific, a manufacturer of dermatological pharmaceuticals for a wide range of conditions. Pain relief remained an untapped market for Aidance until the launch of CBD CLINIC, their first venture into topical analgesics. All CBD CLINIC products are made by the team and facilities already in place at Aidance Scientific’s headquarters in Woonsocket, Rhode Island.
In the summer of 2015, the CBD CLINIC Professional Series began production and became available to healthcare professionals to sell to patients at their practices. Since then, the demand has exceeded company expectations, with the network of registered health professionals who carry CBD CLINIC’s Professional Series in their practice growing daily.
By using only ingredients that are legal federally, the company has found that many patients and doctors are not as resistant to trying a cannabis-related product as they might be otherwise. The de-stigmatization of cannabis-related pain relievers is a big hurdle companies have had to navigate in providing safe and effective pain relief. CBD CLINIC is spearheading the pushback against negative connotations toward cannabis as a medicinal option.
CBD CLINIC products are currently being used by many professional athletes. Most notably, former NFL quarterback Jake Plummer, who has praised the product for its effectiveness as a pain management tool on Twitter.
In addition to Plummer, several athletes and sports medicine figures have also praised CBD CLINIC’s uniquely effective formula and long-lasting effects. Included is Dr. Nelson Vetanze, the first official chiropractor in the NFL, who says, “CBD CLINIC are the best topical analgesic products I have ever used in my practice.”
Following this initial success, CBD CLINIC has decided to launch a Retail Series, which will make their products available outside doctor’s offices, into the wider world of retail distribution. For a new company, bringing a product line into retail can be cost-prohibitive. However, the demand for CBD CLINIC products has prompted the company to begin a crowdfunding campaign on Indiegogo to help speed this process, while also allowing donors to receive product as a reward before they are available to the general public.
Do you want to get involved, check out their funding here at Indiegogo.com.
By donating to the crowdfunding campaign early, supporters can receive the steepest discounts over final retail pricing. Most rewards You can help fund the project at this link. are set to ship as soon as April, since the processes of formulation and manufacturing have already been put into place.
How does it work?
CBD CLINIC ointments and creams are so effective because of their three foundational components: Natural emollients, powerful terpenes, and aromatic cannabidiol (CBD).
The base of each product in CBD CLINIC’s lineup contains all-natural emollients (complex moisturizers) that are readily absorbed by human skin. Choice emollients were hand-selected and combined via a proprietary method to help quickly deliver pain-relieving ingredients into the skin. These help active analgesic compounds penetrate deep into the skin, increasing blood flow to muscle and joints. Notably, there are no cheap synthetic ingredients, like benzyl alcohol or petrolatum.
Terpenes, like menthol and camphor, produce an analgesic reaction by decreasing neuronal excitability, desensitizing the area of pain at the neuron-level. Terpenes are aromatic hydrocarbons found in the essential oils of plants, which produces the plant’s distinct aromas. CBD CLINIC products differ from other CBD-infused pain relievers because, as a result of using Charlotte’s Web CBD hemp oil, they are rich in organic terpenes.
So, in addition to the terpenes added as part of product formulation, there are additional, naturally occurring terpenes present in the CBD oil itself. These are well recognized for their benefits in reducing inflammation, muscle pain, and nerve pain, as well as for overall pain management. They are also considered to add an ‘entourage effect,’ supporting CBD as a neuromodulator of the endocannabinoid system.
Although research into the body’s endocannabinoid system and its ability to be modulated by external cannabinoids is still in the early phases, the British Journal of Pharmacology (among others) have reported that cannabidiol (CBD) has been identified as an allosteric modulator capable of slowing down neurotransmitter signaling. This means that CBD can assist active ingredients already shown to be analgesics in reducing pain.
All three of these components ultimately work together to help interrupt pain signaling by the brain.
You can learn more about CBD CLINIC’s full line of products at their site, cbdclinic.co.
Original article: https://cannabis.net/blog/news/cannabis-cbd-cream-goes-live-on-indiegogo
December 19, 2016 Karen Menehan
Marijuana & Massage: Are CBD Pain-Relief Products Caught Up in New DEA Rule?
At a Glance
DEA Issues New Code for Extract
Cannabidiol (CBD) personal-care products include topical products such as patches, salves and oils, and are created from hemp, a cousin to marijuana. Some massage therapists, chiropractors and the general public have embraced CBD products for pain relief.
Read More Now, many people in the cannabis industry are scrambling to interpret a new rule issued by the Drug Enforcement Administration (DEA) on Dec. 14 titled “Establishment of a New Drug Code for Marihuana Extract”—and to determine if it could affect manufacturers and distributors of hemp-derived products. The rule is scheduled to take effect Jan 13, 2017.
What has resulted is curiosity on the part of some hemp advocates regarding whether or not the new code will have an effect on the CBD industry.
What is seems to come down to is whether a CBD product is ingested or applied topically.
DEA spokesperson Russ Baer told MASSAGE Magazine that CBD lotions, topical ointments and patches are exempt from controls under the Controlled Substances Act, while edible hemp-derived products are not.
Plants of the genus Cannabis include both hemp and marijuana. Industrial hemp contains less than 0.3 percent THC; therefore, CBD oil derived from hemp seeds does not effect the high commonly associated with marijuana, while CBD oil derived from marijuana seeds contains an appreciable amount of THC.
According to the Office of the Federal Register, a new Administration Controlled Substances Code Number was created for marijuana extract in order to better allow quantities of extract material to be tracked apart from quantities of marijuana, and therefore help in complying with international drug control treaties.
The action taken by the DEA was to amend the Code of Federal Regulations related to food and drugs, to include a new subparagraph that creates a new code, 7350, pertinent to CBD extracts. Until now the DEA had used code 7360 for marijuana, or cannabis, and everything derived from it.
Some cannabis advocates say that with this change, the DEA is signaling increased vigilance over interstate hemp-product distribution, while Baer indicated the code change was more along the lines of administrative housekeeping meant to better reflect the activities of scientific research.
“Some attorneys are interpreting it as, ‘This is DEA sending up a red flag’ regarding whether it’s legal to move hemp across state lines or not,” Deputy Director of the National Cannabis Industry Association Taylor West told MASSAGE Magazine.
It’s possible that due to this rule, hemp-derived product distributors could be in violation of federal law when shipping such products across state lines, West said—but whether or not all those distributors were actually in compliance with federal law before now is not clear either.
“Certainly lots of people have made that case [for compliance], but I would not consider that to be a 100-percent accepted theory,” West said.
What is known is that in the 24 states that are in compliance with Section 7606 of the Agricultural Act of 2014, also known as the Farm Bill, it is legal to grow and distribute hemp, because that section “defines hemp as distinct from marijuana and does not treat it as a controlled substance when grown under a compliant state program,” according to a Dec. 14 press release published by the Hemp Industries Association.
Lack of Clarity
Despite laws on the books pertaining specifically to hemp products, there has been a lack of clarity among the public, the media and even hemp advocates about whether hemp-derived CBD products for pain relief fall under the Controlled Substances Act that lists marijuana as a Schedule I drug—a class that also includes LSD and heroin; therefore, many companies have operated under the belief that hemp-derived CBD products were not under the controlled substances act, West added, “and they have been moving products across state lines and selling them in nonregulated areas.”
However, official sources say all forms of cannabis, including hemp, have always been included under Schedule I. For example, the Industrial Hemp Facts published by the Kentucky Department of Agriculture—Kentucky being one of the states that is in compliance with Section 7606 of the federal Farm Bill—reads, “Under the current U.S. drug policy, all cannabis varieties, including hemp, are considered Schedule I controlled substances under the Controlled Substances Act.”
Yet, in recent years, various governmental entities have acknowledged the differences between hemp and marijuana, and have legislated accordingly.
In California, for example, the California Industrial Hemp Farming Act, passed in 2013, revised the definition of marijuana to exclude industrial hemp, and defined industrial hemp as a “fiber or oilseed crop, or both,” that contains less than 0.3 percent of THC and that is intended to be used for fiber or oil derived from the stalks or seeds.
Then in 2014, President Obama signed into law the Farm Bill, which included an amendment to legalize hemp cultivation for research-related purposes.
Yet, just as medical- and recreational-marijuana laws vary from state to state, so too do laws applying to the cultivation of hemp. While some states have approved hemp-cultivation laws, in 20 states and the District of Columbia, cultivation of hemp is illegal.
One thing is clear: As a growing number of U.S. states legalize marijuana for medical or recreational use, the number of people in the general population who are turning to marijuana and its more sedate cousin, hemp, is growing as well.
Even with the lack of consistent regulation, CBD products are big business. According to the Hemp Business Journal CBD Report, by the year 2020 the CBD market will increase by 30 percent to $2.1 billion, with $450 million of that derived from hemp-based sources.
The New Code
According to Baer, the DEA uses a four-digit code for any controlled substance for the purpose of registration, “so whether you are a manufacturer, importer-exporter, or a researcher, anyone that’s handling a controlled substance, you complete that DEA form with a drug code.
“The establishment of the marijuana extract code allows us to process these applications more efficiently and give priority to researchers that are wanting to do medical scientific research on extracts,” he added.
Further, Baer provided input into an article titled “New DEA rule on extracts, CBD causes commotion in cannabis industry,” written by a reporter with The Cannabist online publication. In his email to The Cannabist, Baer said, “We have not changed any control status with this Federal Register Notice … Everything remains schedule I, so no other provisions of the law (registration, security requirements, research protocols, etc.) change. Companies will simple [sic] use a new code for extracts.”
National Hemp Association Assistant Director Alli Cloyd told MASSAGE Magazine she would tell CBD-product manufacturers and users, “Don’t be worried at this point.”
CBD Clinic co-founder David Goldsmith shared Cloyd’s view; he said as soon as his company’s staff heard about the new code, they immediately spoke with legal counsel and were told the code will not have an impact on the hemp industry.
He told MASSAGE Magazine that once the DEA posted the code change on its website, “this got picked up by people in the media who took it as something entirely new and a new threat, when in fact it really isn’t that.”
CBD Products for Pain: Wait and See
Meanwhile, what does all this mean for the companies manufacturing and distributing CBD products, including topical products such as patches, salves and oils intended for pain relief?
According to Goldsmith, CBD topical companies should not be worried by this code change; they should only be be worried if they are making medical claims for which the Food and Drug Administration (FDA) could come after them.
“If you have a CBD topical and all it says is ‘CBD topical for skin,’ that’s not a medical claim,” he said. “You can’t distribute a product that makes medical claims if it doesn’t have an FDA-approved component.”
Others suggest a wait-and-see approach, tempered with caution.
Companies need to realize they have already been operating in a somewhat gray area, West said, “and if you have been told by attorneys that it is not a gray area, they may not be doing you the best service—which is not to say these businesses should not be taking this risk, but they should understand there is a risk involved.”
Of Baer’s statement to The Cannabist, West said Baer seemed to be implying that the DEA is not planning to go out of its way to target CBD companies that are producing hemp-derived CBD products and selling them, “but you can weigh that against the fact that one of the express [DEA] priorities is to prevent interstate commerce of marijuana products, so now you could be opened up to risk that wasn’t as stark before.”
Hemp advocates are ready to fight back should the code change threaten the manufacture and distribution of CBD products.
“DEA has stated that CBD is a controlled substance previously,” stated a Dec. 15 press release from the Hemp Industries Association. “HIA strongly disagrees with the DEA position and is ready to take action to defend should DEA take any action to block the production, processing or sale of hemp under Sec. 7606 [of the Farm Bill].”
Woonsocket company introduces ‘revolutionary’ marijuana alternative for pain
WOONSOCKET – A city-based startup company has created a new pain reliever combining FDA-approved analgesic ingredients with a hemp extract that they say is the first of its kind in the country.
“There’s good news for the estimated 250,000 Rhode Islanders who suffer from chronic pain,” according to a press release on the news from CBD Clinic, working in partnership with Aidance Scientific of Woonsocket.
The company has introduced a line of pain relief products using a hemp extract called cannabidiol that is legal in all 50 states, and reportedly has exclusive rights to formulate with the patented Charlotte’s Web CBD, featured last year in CNN documentaries by Dr. Sanjay Gupta.
“Professional athletes and doctors throughout the U.S. report that CBD Clinic ointments and creams effectively reduce even the most severe muscle and joint pain,” the release explained. Read More
The products are reportedly in use by a number of professional and Olympic athletes including former Denver Broncos quarterback Jake Plummer, who had daily pain from injuries during his decade playing in the NFL, and Duane Ludwig, a professional UFC fighter and trainer who holds the official fastest knockout record in the UFC.
Nelson Vetanze, the first official chiropractor for the NFL, said “CBD Clinic are the best topical analgesic products I have ever used in my practice.”
CBD Clinic products are formulated as over-the-counter non-prescription medications.
“They offer an immediate alternative to the thousands of people in R.I. exploring medical marijuana and other alternatives for treatment of muscle and joint pain, including arthritis, sports injuries, back injuries, neuropathic pain, and pain commonly associated with fibromyalgia, cancer, multiple sclerosis, sciatica, Lyme disease and other ailments,” the press release explained.
Company officials said that the Charlotte’s Web hemp extract in the CBD Clinic product line is nearly devoid of THC – the substance in marijuana that is psychoactive and gets you high. There’s also no concern of THC showing up in drug tests.
“Numerous worldwide studies of the endocannabinoid system suggest that aromatic hydrocarbons in CBD, and similar organic compounds called terpenes, may be effective interrupting pain signaling to the brain, thereby reducing the sensation of pain.”
The CBD Clinic product line was developed in partnership with Aidance Scientific, founded in 2004, which develops and manufactures an extensive line of mostly all-natural, non-prescription dermatology products in its Rhode Island FDA-registered facility. Aidance products are distributed globally and are available at CVS, Walgreens, and other major retailers.
CBD Clinic has embarked on a very different regulatory strategy than the hundreds of companies developing medical marijuana products containing THC. The product line was developed to provide an entirely new class of non-prescription topical medications in the $3 billion topical analgesics market that, according to the company, offers Revolutionary Pain Relie. The company’s mission is to help people throughout the world be as pain-free as possible and have easy access to a cannabis-infused product that “Doesn’t get you high. Just better.” Read Less
Oct 14, 2016
Lebanon, PA, October 14, 2016 (Newswire.com) - Over-the-counter, non-prescription ointments and creams contain natural emollients, powerful terpenes and aromatic Cannabidiol to deliver relief from joint/muscle pain.
Healthy Hemp, LLC (HealthyHemp.com), a recognized online store offering various hemp products that deliver the necessary nutrients for proper body functioning, announced the distribution of the new CBD CLINIC topical pain relief product, available only to doctors and which are FDA-registered and made in an FDA-audited facility. Since its introduction earlier this year, the CBD CLINIC Professional Series over-the-counter, non-prescription ointments and creams have reportedly provided relief to NFL players and other professional athletes regularly exposed to pain-inflicting injuries.
Each formula in the CBD CLINIC Professional Series of creams and ointments contain three foundational components for delivering relief from joint and muscle pain associated with daily living, sports injuries, arthritis, sprains, bruises and related types of inflammation - natural emollients, powerful terpenes and aromatic Cannabidiol. Further, CBD CLINIC products are all formulated with Charlotte's Web Cannabidiol (CBD+CW), a whole-plant extract from a patented Cannabis plant that is nearly devoid of THC, with CBD oil from the plant categorized as an industrial hemp oil extract legal in all 50 states. Read More
Through Healthy Hemp, LLC's distribution of CBD CLINIC pain relief formulas, doctors will have access to the Professional Series five-level system, comprised of Level 1: Mild Odor-Free (containing four-percent Lidocaine, 25mg CBD), Level 2: Mild-Moderate (containing three-percent Camphor and Amica, 50mg CBD), Level 3: Moderate (containing four-percent of Menthol, 75mg CBD), Level 4: Severe (containing seven-percent Menthol and five-percent Camphor, 100mg CBD) and Level 5: Pro Sport (containing 16-percent Menthol and 11-percent Camphor, 200mg CBD). According to Healthy Hemp, LLC and Abascus of Colorado LLC representatives, these options for doctors' patients offer varying levels of pain management, unique formulations and effective doses of Cannabidiol (CBD).
"By formulating non-prescription analgesic creams and ointments with fast absorption properties, powerful deep pain-relieving terpenes and Endocannabinoid Modulators, the next stage in pain management has become a reality," according to Ari Taube, the CEO of Abacus of Colorado creator of CBD Clinic products. "While most CBD on the market is low in terpenes, CBD+CW is rich in organic terpenes that are secreted in the flower's resin gland, where the CBD and terpenes are naturally formed together; we are proud that Healthy Hemp,LLC is offering exclusively to health and wellness professionals these products that are recognized for their benefits in reducing inflammation, muscle pain, nerve pain, stress and overall pain management."
Launched in January 2015 and headquartered in central Pennsylvania, Healthy Hemp,LLC remains the nation's leading distributor of the world-famous Charlotte's Web plant-based extract, enriched with components that nourish and replenish the body. The product, a non-GMO 100-percent vegetarian and gluten-free extract oil, comes in MCT, a fractionated coconut or olive oil that boasts a subtle but pleasing chocolate mint flavor. Healthy Hemp,LLC offers the two oils in multiple strengths and sizes, fulfilling customer expectations of high quality and purity standards.
All members of Healthy HempTM LLC and Healthy Hemp Solutions LLC have no affiliation with FBEC Worldwide, Inc. (stock symbol FBEC), Healthy Hemp Energy, and Wolf Shot Energy.
Healthy Hemp,LLC can be reached by calling (855) 711-HEMP (4367). For more information about the CBD CLINIC products and all of Healthy Hemp's offerings visit https://www.healthyhemp.com/cbd-clinic/
Source: Healthy Hemp, LLC.